NCT02887287

Brief Summary

The study aimed to prove EEN is effective for inducing early clinical remission, mucosal healing, promoting fistula closure and reducing the size of abscess to adult CD patients. They plan to include about 50 patients and observe the effect of EEN.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2013

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2015

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

August 29, 2016

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 2, 2016

Completed
Last Updated

September 2, 2016

Status Verified

August 1, 2016

Enrollment Period

2.3 years

First QC Date

August 29, 2016

Last Update Submit

September 1, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Clinical remission after 12 weeks EEN

    July 2013 to October 2015

Interventions

EENDRUG

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

The detailed inclusion criteria included: 1. \>18 years old 2. Patients with CD was diagnosed clinically according to previously established international criteria \[9\] 3. The diagnosis of stricture, fistula and abdominal abscess was confirmed by ultrasound, CT enterography (CTE), and endoscopy. The bowel stricture should mainly cause by inflammation but not fibrosis. Intolerance or failure to steroids or IFX was judged by medical history 4. The disease was in an active period.

You may qualify if:

  • \>18 years old
  • Patients with CD was diagnosed clinically according to previously established international criteria \[9\]
  • The diagnosis of stricture, fistula and abdominal abscess was confirmed by ultrasound, CT enterography (CTE), and endoscopy. The bowel stricture should mainly cause by inflammation but not fibrosis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The six affiliated hospital of Sun Yat-sen University

Guangzhou, Guangdong, 510000, China

Location

Related Publications (1)

  • Yang Q, Gao X, Chen H, Li M, Wu X, Zhi M, Lan P, Hu P. Efficacy of exclusive enteral nutrition in complicated Crohn's disease. Scand J Gastroenterol. 2017 Sep;52(9):995-1001. doi: 10.1080/00365521.2017.1335770. Epub 2017 Jun 9.

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
committee of the Sixth Affiliated Hospital of Sun Yat-sen University

Study Record Dates

First Submitted

August 29, 2016

First Posted

September 2, 2016

Study Start

July 1, 2013

Primary Completion

October 1, 2015

Last Updated

September 2, 2016

Record last verified: 2016-08

Locations